Clinical Trial Update: Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating panitumumab as monotherapy in metastatic colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Colorectal Cancer, Metastases | Phase 2 | Status: COMPLETED | Results posted: 2013-12-05